New methods to understand how different cell types affect cancer treatment.
Novel Systems Biology Methods for the Cell-type-specific Regulatory Networks Reconstruction from scRNA-seq Data
This study is looking at how individual cells in tumors behave and communicate, using advanced technology to better understand their unique characteristics, so we can create more personalized and effective cancer treatments just for you.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Saint Louis University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10579768 on NIH RePORTER |
What this research studies
This research focuses on using advanced single-cell RNA sequencing (scRNA-seq) technologies to analyze the unique gene expression profiles of individual cells within tumors. By reconstructing specific regulatory networks for different cell types, the project aims to address the challenges posed by cellular diversity in cancer. The approach involves developing innovative computational methods to handle missing data in scRNA-seq datasets, which can enhance the accuracy of personalized treatment strategies for patients with complex diseases. Ultimately, this research seeks to improve the effectiveness of cancer therapies by tailoring them to the specific cellular makeup of a patient's tumor.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with various types of cancer who may benefit from personalized treatment approaches.
Not a fit: Patients with non-malignant conditions or those whose cancers are not amenable to targeted therapies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized cancer treatments that are tailored to the unique cellular characteristics of individual patients.
How similar studies have performed: Other research has shown promising results using single-cell RNA sequencing to improve understanding of cancer heterogeneity, indicating that this approach has potential for success.
Where this research is happening
Saint Louis, United States
- Saint Louis University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Gong, Haijun — Saint Louis University
- Study coordinator: Gong, Haijun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.